Rapid discrimination between methicillin-sensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry by Edwards-Jones, Valerie et al.
TECHNICAL NOTE
Rapid discrimination between methicillin-sensitive
and methicillin-resistant Staphylococcus aureus by
intact cell mass spectrometry
VALERIE EDWARDS-JONES, M. A. CLAYDON, D. J. EVASON, J. WALKER{, A. J. FOX{ and
D. B. GORDON
Department of Biological Sciences, Manchester Metropolitan University, Chester Street, Manchester M1
5GD and {Manchester Public Health Laboratory, Withington Hospital, Nell Lane, West Didsbury, Manchester
M20 8LR
Rapid, accurate discrimination between methicillin-sensitive Staphylococcus aureus
(MSSA) and methicillin-resistant S. aureus (MRSA) strains is essential for appropriate
therapeutic management and timely intervention for infection control. A rapid method
involving intact cell mass spectrometry (ICMS) is presented that shows promise for
identification, discrimination of MSSA from MRSA and typing. In ICMS, cells from a
bacterial colony are emulsified in a chemical matrix, added to a sample slide, dried and
analysed by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry
(MALDI-TOF-MS). This technique examines the chemistry of the intact bacterial cell
surface, yielding spectra consisting of a series of peaks from 500 to 10 000, which
represent the mass:charge (m:z) ratios. Each peak corresponds to a molecular fragment
released from the cell surface during laser desorption. Specimens can be prepared in a
few seconds from plate cultures and a spectrum can be obtained within 2 min. ICMS
spectra for 20 staphylococcal isolates showed characteristic peaks, some of which were
conserved at species level, some at strain level and some were characteristic of the
methicillin susceptibility status of the strain. ICMS may have potential for MRSA
identification and typing, and may improve infection control measures.
Introduction
Staphylococcus aureus is one of the most commonly
isolated pathogens [1], accounting for c. 46% of
infections in intensive care units [2] and hospital
outbreaks of methicillin-resistant S. aureus (MRSA) are
a worldwide problem. Rapid differentiation of MRSA
from methicillin-sensitive S. aureus (MSSA) is essen-
tial for appropriate therapy and timely intervention for
cross-infection control, but conventional methods are
time-consuming and costly [3]. Subtyping of MRSA in
putative outbreaks increases costs and adds further
delay. The emergence of epidemic MRSA (EMRSA),
such as types 15 and 16 in England and Wales [4],
increases the requirement for fine discrimination in
typing. Molecular subtyping methods, e.g., pulsed-field
gel electrophoresis (PFGE), provide finer discrimina-
tion than the traditional phage-typing technique, but
take several days to perform [5]. Although rapid
methods to detect methicillin resistance based on the
mecA PCR have been developed [6], there are
problems. The mecA gene occurs in some coagulase-
negative staphylococci (CNS) and in some strains of S.
aureus that are phenotypically methicillin sensitive [7].
Mass spectrometry has been used widely for identifica-
tion and typing of micro-organisms [8, 9]. Early work
involved solvent extraction and chemical modification
before analysis, but some methods use simple specimen
preparation and direct analysis via appropriate ionisa-
tion methods [10]. Fast atom bombardment, electron
impact and electrospray ionisation are extensively used
for analysis of solvent extracts or volatile derivatives
[11, 12]. Prior separation of components of mixtures by
chromatographic procedures, sometimes on-line by
direct coupling to the mass spectrometer, has also
been employed [13]. Until recently [14], whole-cell
analysis has centred on pyrolysis mass spectrometery
[15]. All these approaches have drawbacks: compli-
cated sample preparation or extraction procedures,
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Fig. 1. The spectra obtained from three replicates of S. aureus NCIMB 8625.
2
9
6
V
.
E
D
W
A
R
D
S
-JO
N
E
S
E
T
A
L
.
complex chemical derivatisations, cumbersome data
analysis or poor inter-batch reproducibility.
Matrix-assisted laser desorption ionisation time-of-
flight mass spectrometry (MALDI-TOF-MS) is an
established technique for profiling bacterial proteins
from cell extracts [16]. Recently, this technique has
been applied to intact bacterial cells technique termed
intact cell mass spectrometry (ICMS), providing a
reproducible spectrum within minutes [14, 17]. Bacter-
ial cells are applied to a sample slide, matrix is added
and the slide is transferred to the mass spectrometer.
Here, a laser beam vaporises the matrix, which carries
away and ionises large mol. wt. (500–10 000) frag-
ments from the cell surface into the vapour phase.
These ions are extracted into a drift tube, where they
separate and are sequentially delivered to a detector in
order of their mass:charge (m:z) ratio. Negative and
positive ions are produced and either can be analysed.
This report summarises preliminary experiments in
which ICMS was applied to discrimination between
MRSA and MSSA.
Materials and methods
Strains comprised: seven strains of MSSA (ATCC
13301, ATCC 25923, NCIMB 11195, NCIMB 6571,
ATCC 27659, NCIMB 8625 and NCIMB 11852);
seven hospital isolates of MRSA that had been typed
by PFGE and conventional phage typing (provided by
Manchester Public Health Laboratory, Withington
Hospital, Manchester); and six strains of CNS (S.
saprophyticus NCIMB 8711, a clinical isolate of S.
warnerii, S. cohnii NCTC 11041, S. haemolyticus
NCTC 11042, S. epidermidis NCTC 7944 and S.
epidermidis NCTC 11047). These were cultured on
Columbia Blood Agar (CBA; Lab M, Wash Lane,
Bury, Lancs) with horse blood (HBO 34; TCS,
Botolph Claydon, Bucks) 5%, incubated overnight at
378C.
A single colony was removed with a sterile plastic loop
and smeared on to the appropriate segment of a sample
slide (Kratos Analytical, Salford, Lancs), taking 10
replicates of each isolate. Matrix solution (1 l of a
saturated solution of 5-chloro-2 mercapto-benzothia-
zole dissolved in a water:methanol:acetonitrile 1:1:1
mix, containing formic acid 0.1% and 0.01 M of 18
Crown-6 ether) was added to each sample and allowed
to dry.
Samples were analysed with a Kompact MALDI 2
linear, time-of-flight mass spectrometer (Kratos Analy-
tical), desorbing with a 3-ns pulse of nitrogen laser
light (337 nm wavelength) of intensity just above the
threshold for ion production. Positive ions were
extracted with an accelerating voltage of þ20 kV
[13]. Spectra for individual specimens were compiled,
averaging results from 100 shots taken across the width
of the specimen for m:z values 500–10 000. Spectra for
the 10 replicates were compared to determine within-
isolate peak reproducibility, then summed to minimise
random effects of baseline drift and noise. Only peaks
with intensities .0.4 mV after baseline subtraction
were considered in the analysis. The presence and
absence of peaks were considered as fingerprints for
the particular isolate.
Table 1. Summary of the m:z values found in all staphylococcal isolates tested
m:z value All staphylococci MSSA MRSA Other species
511 511 511 sco, sha, ssa
525 525
552 552 sco, sep, sha, ssa
563 563 563 sco, sep, sha, ssa
617 617
640 640 640 sco, sep, sha, ssa
734 734
743 743 743 sco, ssa, swa
760 760
767 767 767 swa
773 773 773 sco, sep, ssa
787 787
798 798
826 826
854 854 854 swa
891 891
999 999 999 swa
1026 1026 1026 swa
1140 1140
1165 1165
1229 1229
2127 2127
2548 2548
2647 2647
Numbers in bold type denote the presence of peaks in all the staphylococcal species tested, i.e.,
potential genus markers. sco, S. cohnii; sep, S. epidermidis; ssa, S. saprophyticus; sha, S.
haemolyticus; swa, S. warnerii.
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Fig. 2. Typical spectra: (a) MSSA, (b) MRSA.
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Results were transferred to Excel spreadsheets and
subjected to hierarchical cluster analysis by using the
Dice similarity coefficient in the statistical suite SPSS
for Windows.
Results and discussion
Within-strain reproducibilty was good; peaks were
resolved with 0.1% reproducibility (manufacturer’s
specification) on the mass:charge (m:z) scale. Over
90% of the peaks were reproduced in all replicates
and relative intensities (but not absolute intensities)
were closely comparable. Other studies (unpublished
data) have shown little loss in reproducibility between
batches analysed on different days. Most peaks were
found in the m:z range 500–2000. Typical replicate
spectra for MSSA (NCIMB 8625) are shown in
Fig. 1.
Peak conservation is illustrated in Table 1. Some peaks
(at m:z 525, 617, 734, 760, 787, 798 and 826) were
present in all isolates, some were invariably present in,
and unique to, MRSA (e.g., 891, 1140, 1165, 1229 and
2127) or MSSA (e.g., 2548 and 2647) and many were
unique to individual strains. MSSA strains produced
small numbers of peaks (37–67) and MRSA strains
produced more (82–209), allowing ready visual
discrimination. The spectra of the CNS showed marked
inter-species differences, but could be divided into two
broad groups, one with few peaks (30–48) comprising
S. epidermidis and S. warneri, and the other with 92–
106 peaks, comprising S. haemolyticus, S. saprophyti-
cus and S. cohnii. Spectra were readily discriminated
on visual inspection into the tight distinct MRSA and
MSSA groups and a widely varied, but distinct
miscellany of CNS strains.
At a finer level of discrimination, there were visually
obvious differences between almost all the MRSA
isolates, particularly in the peak patterns within m:z
ranges 1100–1250, 1290–2040 and 3060–3220. How-
ever, two pairs of MRSA isolates were not readily
distinguished in ICMS either visually or in mathema-
tical analysis (Dice coefficient .70% similarity). These
pairs were also indistinguishable by phage and PFGE
typing: one pair were both EMRSA 15 PFGE type 5
and the other were both EMRSA 16 PFGE type 1.
These were the only pairs among the MRSA isolates
that were indistinguishable by conventional typing.
The clarity of discrimination between MSSA and
MRSA strain spectra (Fig. 2) and the speed of the
method suggest a potential role for ICMS in the
diagnostic laboratory. Up to 10 isolates, with 10
replicates of each, could be analysed and categorised
per hour. Conventional approaches that distinguish
between MRSA and MSSA are slow. This introduces
delays in guided treatment decisions and leaves little
opportunity for the early intervention that is essential to
limit the spread of MRSA. ICMS offers an opportunity
to minimise the delay, and so reduce the financial and
human costs of MRSA nosocomial infections. There is
the additional benefit that ICMS has potential as a
finely discriminatory typing tool, which is clearly
pertinent to this application. From these preliminary
results, ICMS spectra appear to contain data that are
relevant at three levels: species identification, typing at
a gross level into MRSA or MSSA, and typing at the
fine level attained in PFGE. If this is so, then there are
many further applications for ICMS in medical
microbiology. However, there is a clear need for larger
scale trials to be undertaken before these claims can be
confirmed.
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